AU Stock MarketDetailed Quotes
MEBOC Medibio Ltd
- 0.001
- 0.0000.00%
20min DelayTrading Apr 12 10:00 AET
457.04KMarket Cap0.00P/E (Static)
0.000High0.000Low0Volume0.000Open0.001Pre Close0.00Turnover0.00152wk High0.00%Turnover Ratio457.04MShares0.00152wk Low--EPS TTM332.51KFloat Cap0.008Historical High0.00P/E (Static)332.51MShs Float0.001Historical Low--EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
Medibio Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | (FY)Jun 30, 2015 | (FY)Jun 30, 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -44.87%22.07K | -60.61%40.04K | -23.85%101.66K | -63.39%133.5K | 77.97%364.63K | 786.92%204.88K | 24.86%23.1K | 18.5K | ||
| Operating revenue | -44.87%22.07K | -60.61%40.04K | -23.85%101.66K | -63.39%133.5K | 77.97%364.63K | 786.92%204.88K | 24.86%23.1K | --18.5K | ---- | ---- |
| Cost of revenue | -85.23%158 | -99.37%1.07K | -16.60%170.7K | -9.47%204.69K | 198.79%226.09K | 75.67K | ||||
| Gross profit | -43.76%21.92K | 156.44%38.97K | 3.01%-69.04K | -151.39%-71.19K | 7.22%138.54K | 459.35%129.21K | 24.86%23.1K | 18.5K | ||
| Operating expense | -25.16%2.75M | 43.33%3.68M | -41.16%2.57M | -56.12%4.36M | -47.19%9.94M | 48.46%18.82M | 73.25%12.67M | 96.83%7.32M | 369.74%3.72M | 7.97%791.28K |
| Selling and administrative expenses | -22.60%831.76K | -10.05%1.07M | -51.23%1.19M | -63.36%2.45M | -33.24%6.68M | 219.75%10.01M | 58.17%3.13M | 42.86%1.98M | 266.84%1.39M | -18.70%377.78K |
| -Selling and marketing expense | 286.80%77.96K | 184.19%20.16K | 674.24%7.09K | -99.23%916 | -77.10%119.43K | 122.05%521.53K | 21.11%234.86K | 127.38%193.93K | 258.56%85.29K | -53.56%23.79K |
| -General and administrative expense | -28.51%753.8K | -11.21%1.05M | -51.50%1.19M | -62.70%2.45M | -30.83%6.56M | 227.67%9.49M | 62.19%2.9M | 37.32%1.79M | 267.39%1.3M | -14.38%354K |
| Research and development costs | -61.74%307.15K | 86.39%802.9K | 19.67%430.77K | -8.85%359.95K | -87.87%394.91K | -24.66%3.26M | 133.15%4.32M | 779.73%1.85M | 1,295.96%210.66K | 486.51%15.09K |
| Depreciation amortization depletion | 41.02%541.03K | 93.27%383.67K | 33.35%198.52K | --148.87K | ---- | -23.01%1.33M | 36.85%1.73M | 144.32%1.26M | --516.46K | ---- |
| -Depreciation and amortization | 41.02%541.03K | 93.27%383.67K | 33.35%198.52K | --148.87K | ---- | -23.01%1.33M | 36.85%1.73M | 144.32%1.26M | --516.46K | ---- |
| Other operating expenses | -24.30%1.07M | 90.96%1.42M | -47.11%741.53K | -50.95%1.4M | -32.26%2.86M | 20.71%4.22M | 57.40%3.5M | 38.47%2.22M | 302.61%1.6M | 52.01%398.41K |
| Operating profit | 24.96%-2.73M | -38.10%-3.64M | 40.55%-2.63M | 54.78%-4.43M | 47.56%-9.8M | -47.71%-18.69M | -73.37%-12.65M | -96.33%-7.3M | -369.74%-3.72M | 13.28%-791.28K |
| Net non-operating interest income (expenses) | -106.51%-13.26K | 57.06%-6.42K | 48.66%-14.95K | -280.35%-29.13K | -87.61%16.15K | 156.09%130.36K | 19.34%-232.42K | -87.34%-288.15K | -53.43%-153.81K | 46.00%-100.25K |
| Non-operating interest income | ---- | 70.68%2.27K | -82.41%1.33K | -74.86%7.56K | -78.28%30.08K | 304.49%138.5K | 35.31%34.24K | 271.44%25.31K | -2.34%6.81K | -12.11%6.98K |
| Non-operating interest expense | 149.34%13.26K | -15.47%5.32K | -76.35%6.29K | --26.6K | ---- | -96.95%8.14K | -14.93%266.66K | 95.15%313.46K | 49.80%160.62K | -44.61%107.22K |
| Total other finance cost | ---- | -66.24%3.37K | -0.99%9.99K | -27.55%10.09K | --13.93K | ---- | ---- | ---- | ---- | ---- |
| Other net income (expenses) | 95.85%-376.42K | -880.09%-9.07M | 97.69%1.16M | -81.59%588.22K | 41.59%3.2M | -27.17%2.26M | 75.97%3.1M | 143.48%1.76M | -974.56%-4.05M | 32,611.44%463.19K |
| Special income (charges) | 86.87%-1.32M | ---10.04M | ---- | 62.42%-203.55K | ---541.68K | ---- | ---- | ---- | ---4.31M | ---- |
| -Less:Impairment of capital assets | -86.87%1.32M | --10.04M | ---- | -62.42%203.55K | --541.68K | ---- | ---- | ---- | --4.31M | ---- |
| Other non-operating income (expenses) | -2.46%941.69K | -16.98%965.41K | 46.87%1.16M | -78.82%791.77K | 65.58%3.74M | -27.17%2.26M | 75.97%3.1M | 590.35%1.76M | -44.92%255.12K | 32,611.44%463.19K |
| Income before tax | 75.47%-3.12M | -755.36%-12.72M | 61.61%-1.49M | 41.21%-3.87M | 59.59%-6.59M | -66.58%-16.3M | -68.00%-9.79M | 26.48%-5.82M | -1,749.43%-7.92M | 60.94%-428.33K |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 75.47%-3.12M | -755.36%-12.72M | 61.61%-1.49M | 41.21%-3.87M | 59.59%-6.59M | -66.58%-16.3M | -68.00%-9.79M | 26.48%-5.82M | -1,749.43%-7.92M | 60.94%-428.33K |
| Net income continuous operations | 75.47%-3.12M | -755.36%-12.72M | 61.61%-1.49M | 41.21%-3.87M | 59.59%-6.59M | -66.58%-16.3M | -68.00%-9.79M | 26.48%-5.82M | -1,749.43%-7.92M | 60.94%-428.33K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 75.47%-3.12M | -755.36%-12.72M | 61.61%-1.49M | 41.21%-3.87M | 59.59%-6.59M | -66.58%-16.3M | -68.00%-9.79M | 26.48%-5.82M | -1,749.43%-7.92M | 60.94%-428.33K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 75.47%-3.12M | -755.36%-12.72M | 61.61%-1.49M | 41.21%-3.87M | 59.59%-6.59M | -66.58%-16.3M | -68.00%-9.79M | 26.48%-5.82M | -1,749.43%-7.92M | 60.94%-428.33K |
| Diluted earnings per share | ||||||||||
| Basic earnings per share | ||||||||||
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data